Membrane related effects in endothelial cells induced by human cytomegalovirus. 1995

A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
Department of Medical Microbiology, University Hospital of Maastricht, The Netherlands.

Previously, we have reported on the increase in procoagulant activity of human umbilical vein endothelial cells (HUVEC) after infection with human cytomegalovirus (HCMV). When using microvascular endothelial cells from foreskin (MVEC), we also observe a significant increase in membrane perturbation and a concomittant increase in procoagulant activity. This effect is both observed with a laboratory HCMV strain (AD169) with low pathogenicity for endothelium and a HUVEC adapted strain (VHL-E) that readily infects endothelial cells. We compared the membrane perturbation of two types of endothelial cells, HUVEC and MVEC with human embryonal fibroblasts (HEF), being fully permissive for both strains. A membrane effect was only found in endothelial cells. Our results suggest that HCMV induces in MVEC more merocyanine-540 incorporation in the membrane as in HUVEC. The increase in the procoagulant activity induced by HCMV was more pronounced in MVEC than in HUVEC. Inactivated virus, as well as virus pre-incubated with heparin was unable to evoke membrane perturbation. It therefore appears that HCMV induces a rapid membrane response in vascular endothelium and that physical interaction of the virion and the endothelial cell is required to elicit this response.

UI MeSH Term Description Entries
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
August 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
August 1989, Journal of medical virology,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
April 1979, The Journal of general virology,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
June 1988, Journal of medical virology,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
June 2006, Journal of cell science,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
January 1994, Blood,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
December 1984, The Journal of infectious diseases,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
January 1986, Archives of virology,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
August 2018, Experimental and therapeutic medicine,
A G van Geelen, and M E Slobbe-van Drunen, and A D Muller, and C A Bruggeman, and M C Van Dam-Mieras
January 1989, Archives of virology,
Copied contents to your clipboard!